|
|
Volumn 28, Issue 11, 2010, Pages 1139-1140
|
|
Shire's replacement enzymes validate gene activation
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AGALSIDASE ALFA;
AGALSIDASE BETA;
AMPHETAMINE;
DEXAMPHETAMINE;
IDURONATE 2 SULFATASE;
NOVEL ERYTHROPOIESIS STIMULATING PROTEIN;
RECOMBINANT ERYTHROPOIETIN;
DRUG APPROVAL;
DRUG INDUSTRY;
DRUG LEGISLATION;
DRUG MANUFACTURE;
DRUG MARKETING;
ENZYME REPLACEMENT;
FABRY DISEASE;
FOOD AND DRUG ADMINISTRATION;
GAUCHER DISEASE;
GENE ACTIVATION;
GENE TECHNOLOGY;
GENE THERAPY;
HUMAN;
HUNTER SYNDROME;
IMMUNOGENICITY;
LAW SUIT;
NOTE;
PRIORITY JOURNAL;
PROMOTER REGION;
PROTEIN GLYCOSYLATION;
CELL LINE;
DRUG CONTAMINATION;
DRUG INDUSTRY;
ENZYME REPLACEMENT THERAPY;
HUMANS;
PATENTS AS TOPIC;
REPRODUCIBILITY OF RESULTS;
TRANSCRIPTIONAL ACTIVATION;
|
|
EID: 78149289065
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt1110-1139a Document Type: Note |
|
Times cited : (13)
|
|
References (0)
|
